Scanned image of the page. Keyboard directions: use + to zoom in, - to zoom out, arrow keys to pan inside the viewer.

Page Options

Download this Issue


Something wrong?

Something wrong with this page? Report problem.

Rights / Permissions

This collection, digitized in collaboration with the Michigan Daily and the Board for Student Publications, contains materials that are protected by copyright law. Access to these materials is provided for non-profit educational and research purposes. If you use an item from this collection, it is your responsibility to consider the work's copyright status and obtain any required permission.

February 21, 2002 - Image 10

Resource type:
The Michigan Daily, 2002-02-21

Disclaimer: Computer generated plain text may have errors. Read more about this.




FEBRUARY 21, 2002


Goalie fighting his way into Yost ARUN

By J. Brady McCoough
Daily Sports Writer
If there's one thing Alvaro Montoya
- fresh off his 17th birthday - should
work on before he sports the maize and
blue sweater next fall, it's controlling his
Montoya, a goaltender for the U.S.
National Develop-
ment Program
Under-17 team, is
currently serving a
two-game suspen-
sion for fighting
during one of Team
USA's games last
"He's a competi-
tive young man,"
Team USA coach Montoya
Moe Mantha said.
"He competes day in and day out and
wants to win badly. He takes it pretty
If things go as planned, Montoya will
fast-track through his last two years at
Ann Arbor Huron High School and suit
up for the Wolverines next fall.

He'll be filling the shoes of senior
netminder Josh Blackburn, who along
with fellow senior Kevin O'Malley will
graduate and force Michigan to have
two freshman goaltenders on its roster in
2002. It will be the fourth consecutive
time that a Michigan goaltender started
as a freshman, as Steve Shields, Marty
Turco and Blackburn all did the same.
Montoya is currently balancing a
heavy work schedule with classes and
two or three games per week with Team
USA. The Illinois native is taking class-
es through the mail to make sure he fin-
ishes his requirements on time.
"It's tough, but I'm getting there,"
Montoya said. "Some nights I just have
to tell my friends that I can't go out."
Because of his limited experience and
young age, Montoya knows that there
will be plenty of doubters in his first
season Jaking the ice at Yost Ice Arena.
"Let them doubt," Montoya said.
"I just have to go prove myself and
play like I play and show them what
I can do."
Montoya has been in this position
before. When he played for the Texas
Tornado of the North American Hockey

League, most members of the Tornado
were 19 or 20 years old, but Montoya
joined when he was just 15.
"He's tremendously talented for his
age," said Michigan defenseman Nick
Martens, who played with Montoya in
Texas. "He was able to compete with 18
19 and 20 year olds. You could tell in
practice that he has unbelievable poten-
tial, and I'm pretty excited that he's
coming here."
Mantha admitted that his current
goaltender has some maturing to do
before he's fully ready for Division I
hockey and said that Montoya will be
shocked at first by the speed of shots
he'll face from 21 and 22 year olds. He
has been impressed with Montoya's
preparation before games and his com-
munication with his teammates, among
other things.
"He loves to challenge the shooter
and is not afraid of the shot," Mantha
said. "He loves to play the puck."
Said Martens: "I used to have one-on-
one battles with him, and he'll do any-
thing to keep the puck out of his net. He
hates to get scored on. That's a huge per-
sonality trait for any goalie."



T ankers open Big Tens in second

Michigan coach Sue Guevara praised Raina Goodlow for her excellent defense, but
a staph infection has kept the 6-foot-2 forward on the sidelines since Dec.:1.
Crutch-free: Goodlow
et tin her hops back

By Kyle O'Neill
Daily Sports Writer

Thanks to two top-four finishes, the
Michigan women's swimming and div-
ing team found itself tied for second in
the Big Ten Championships after last
night's two opening relays.
Michigan's 200-yard medley relay
(Erin Abbey, Kelli Stein, Annie Weil-
bacher and Laura Kaznecki) finished
second behind Penn State with a time
of 1:41.59 - eight tenths of a second

better than last year's team at Big Tens.
Wisconsin stole the show last night,
though, with its dominating perform-
ance in the 800-yard freestyle relay.
With a time of 7:14.6, the Badgers
were five seconds ahead of their near-
est competitor.
Michigan's quartet of Amy McCul-
lough, Emily-Clare Fenn, Sara Johnson
and Andrea Kurrle earned a fourth-
place finish (7:20.35).
With the win in the final event, the
Badgers are alone atop the leaderboard

with 68 points. Michigan and Indiana
follow with 64 points each.
Today, No. 18 Michigan will hope to
make up the four-point differential as it
will compete in the 200-yard freestyle
relay, 200 free, 50 free, 200 individual
medley, 400 medley relay and 1-meter
Preliminary events are at 11 a.m.
and the finals are at 7 p.m. at Canham
Natatorium. Diving finals will consist
of two rounds, one in the morning ses-
sion and one in the evening.

Gophers standing in way of title

By M.Iude Kebler
Daily Sports Writer
Last year, the Minnesota men's swimming and diving
team left no doubt that it was the best team in the Big Ten.
As hosts of the conference championships, the Gophers
swam away from the competition, winning by a margin of
almost 250 points. Michigan placed second, fol-
lowed closely by Penn State.
This year, the Wolverines hope to return to BLOOM
the top of the Big Teri, but getting past the what: Big Ten
Gophers won't be easy. The championships When: Feb.28
will be held Feb. 28 through March 3 in Latest: Michi~
Bloomington. No. 6 Minnesota won't hold a conference tit
home-pool advantage this time around, but it seasons that A
does have an edge over No. 10 Michigan in the has coached.
sprint relays and in the 100-yard backstroke,'
breaststroke and butterfly races, according to Michigan
coach Jon Urbanchek.
"They're definitely the favorites to win the Big Tens,"
Urbanchek said. "Minnesota looks very strong on paper, but
I always say, 'We don't swim on paper, we swim in water."'
The Wolverines are counting on their strength in the dis-
tance events - the 1650-yard and 500-yard freestyles and
the 400-yard individual medley - to help them make a run
for the conference title. Michigan is anchored by two stand-
out distance-swimming freshmen, Brendan Neligan and
Andrew Hurd. The team will also return four of five Wolver-
ines who were named to the All-Conference team last year:
Dan Ketchum, Tim Siciliano, Garrett Mangieri and Jordan
Watland. Ketchum was named 2001 Big Ten Freshman of

the Year, the ninth Wolverine to receive the award.
On the diving side, sophomore Jason Coben led the team
all year and last Tuesday was named the Big Ten Diver of the
Week for the second time this season.
Overall, the championship meet will be the fastest one the
Wolverines have participated in all year. The team finished
the season with four consecutive dual meet wins but won the

S- March 2
gan has won 12
les in the 19
Jon Urbanchek

last few competitions easily, often with swim-
mers changing up their events in order to relax
and prepare for the conference championships.
"The Big Ten is one of the toughest confer-
ences in the nation, and it is difficult to win,"
Urbanchek said.
The team competition aspect of the Big Ten
Championships is important, but equally
important is the fact that most swimmers turn
in their fastest times of the year at the meet.

By Jim Weber
Daily Sports Writer
Raina Goodlow will be on 4he floor
tonight when Michigan faces North-
western - on her teammates' shoes,
that is.
Despite missing the last 20 games,
Goodlow's teammates and coaches
haven't forgotten about her, putting
pieces of tape with her name and num-
ber on shoes, arm-bands, warm-ups or
in coach Sue Guevara's case - a sports
jacket. Goodlow admitted this show of
support from her teammates made her
For Goodlow, the last two-and-a-half
months have been a roller coaster of
emotions. Her nightmare began on
Dec. 1 - the day before the team was
supposed to play defending champion
Notre Dame. After laying down for a
nap, her hips started to hurt her, and
she was unable to move her legs with-
out pain. She was taken to the hospital,
but doctors could not figure out what
was wrong.
"I wasn't necessarily scared at first.
But when I got in the hospital and they
had to take these heart tests and MRI's
- that's when I started to get scared,"
Goodlow said.
Initially, it was reported that she
missed the Notre Dame game with
back spasms, but the problem was
much more severe. The doctors eventu-
ally discovered that Goodlow was suf-
fering from a mysterious staph
Said Goodlow: "No one knows
where it came from."
After all the tests, she remained in
the hospital for another two weeks.
During the stay, Goodlow was given
antibiotics through an IV and needed a
wheelchair to get around.

Who: Michigan (5.9 Big Ten, 15.10 overall) at
Northwestern (0-14, 4-21)
When: 7 p.m.
Latest: Northwestern has lost 40 straight Big
Ten regular season games, including a seven-
point loss to Michigan earlier this season.
"A lot of people thought I was para-
lyzed," she said. "But I could move my
legs, it just hurt really bad when I was
moving them."
Goodlow eventually was able to walk
around her room with a walker, and she
was on crutches by the time she left the
hospital. Since then, those crutches
have been her mode of transportation to
the team's home games and practices.
Off her crutches for just a week and
a half, she is now able to fully function
- except for playing basketball. Good-
low is not expected to return to the
court until the summer, when she will
begin training for next season as a
fifth-year senior. Goodlow is currently
doing "jump training," but admits she
hasn't made much progress yet.
"My vertical is like two inches, but it
is a start," Goodlow said.
She and Guevara agree that Good-
low's presence would have brought two
things the team has lacked this season:
Defense and leadership. Guevara said
she wished she could have used her 6-
foot-2 forward this past Sunday to
guard Purdue's Shereka Wright, who
scored 40 points against the Wolver-
ines, because of Goodlow's athleticism
and long arms and legs. Guevara also
said Goodlow did a nice job of leading
by example before her infection.
Everyone on the team is asking
"What if?"
Michigan will find out next year.


victory may
be biggest
upset ever
s the final seconds ticked off in
Belarus' amazing 4-3 win over
weden in the quarterfinals of
the Olympic hockey tournament yester-
day, one of NBC's commentators pro-
claimed the victory "the greatest upset
in Olympic hockey since the introduc-
tion of the current tournament format."
With all due respect to NBC's ana-
lysts, I'd take that a step further. I think
Belarus' shocking win yesterday was the
single greatest upset in Olympic hockey
Yes, even greater than the 1980 "Mir-
acle On Ice" orchestrated by the United
States. The Americans' 4-3 defeat of the
vaunted Soviet team in Lake Placid is
widely considered the biggest upset in
sports history, let alone Olympic hockey.
By touting yesterday's win by
Belarus, I'm not saying that the "Mira-
cle On Ice" wasn't a monumental win
for the U.S. The Soviets had won four
straight Olympic gold medals heading
into Lake Placid, but that run came to a
halt when the U.S. stunned them in the
semifinals. But, while what the U.S.
accomplished 22 years ago was certain-
ly memorable, I think what Belarus
pulled off yesterday against Sweden was
even more improbable. For those of you
who think I'm absolutely crazy, consider
First off, let's compare the heavily-
favored teams that lost -the Soviet
Union in 1980 and Sweden this year.
The Soviet team contained several hock-
ey legends, such as goaltender Vladislav
Tretiak and defensemanViacheslov
Fetisov. Following the loss in Lake
Placid, the Soviets won three more gold
medals in a row to complete a rui of
seven golds in eight Olympiads.
This year's Swedish team isn't that
kind of juggernaut. But, the Swedes are
a hockey powerhouse in their own right
-they won the gold medal at the Lille-
hammer Olympics in 1994 and are one
of the four best hockey-playing nations
in the world (along with Russia, Canada
and the United States). The Swedes
boasted several future Hall of Famers
(such as center Mats Sundin and
defenseman Nicklas Lidstrom), and they
demonstrated just how good they were
when they embarrassed Canada, 5-2, in
the opening game of the medal round.
Now we'll look at the two underdogs,
the 1980 U.S. "Miracles on Ice" and the
2002 Belorussians. The U.S. team -
composed of college players -wasn't
expected to win the gold, and nobody
thought they could take down the Sovi-
ets. While that makes their win impres-
sive, it's not like the U.S. was some
third-world country. As much as the
Soviets were expected to win, it was still
the United States Olympic team, which
makes it hard for me to think of them as
true "underdogs"
That contrasts with Belarus, which
redefines the term "underdog." The
Belorussians had to go through three
preliminary games just to qualify for the
round-robin tournament, which the
1980 U.S. team didn't have to do. Then
they had to play Russia, Finland and the
U.S. (Belarus lost all three of those
games). Yesterday's game against Swe-
den was the Belorussians' seventh game
in 12 days, and it showed - they were
exhausted by the middle of the second
period. Toss in the fact that almost all of
Sweden's team plays in the NHL while
Belarus has one NHL player, and you
can see that Belarus had almost no shot.
This brings us to my final point. The
only reason the U.S. had a chance

against the Soviets in 1980 was that the
game was played in upstate New York,
in front of thousands ofAmericans wav-
ing flags and chanting "U-S-A!" at the
height of the Cold War. To say that the
U.S. had a home-ice advantage would be
an understatement.
On the other hand.;Belarus had about
10 fans cheering for it against Sweden.
The E Center was probably three-
fourths empty, since nobody thought
Sweden would lose. With no crowd sup-
port and with three of its players going
down with injuries, Belarus still man-
aged to beat the top-seeded team in the


All the teams in the conference have trained and tapered for
Big Tens, and the goal is to take home a championship ring
while at the same time putting up NCAA automatic qualify-
ing times.
"One of our goals is obviously to win the Big Ten, but we
also want to get as many people to qualify for NCAAs as we
can," Urbanchek said.
The coach said that if all goes-well, as many as 12 Wolver-
ines could be headed to the national championships March
Still, Urbanchek doesn't want anyone to get the wrong
idea about Michigan's attitude.
"We want to win, we just have to overcome some obsta-
cles," he said.

1 1

Contraceptive Injection

3irtk con-~trol you tkir* agourt just i+x a ear

medroxyprogesterone acetate injectable suspension

DEPO-PROVERAO Contraceptive Injection
(medroxyprogesterone acetate injectable suspension, USP)
This product is intended to prevent pregnancy. It does not protect against HIV
infection (AIDS) and other sexually transmitted diseases.
What is DEPO-PROVERA Contraceptive Injection?
DEPO-PROVERA Contraceptive Injection is a form of birth control that is given as an
intramuscular injection (a shot) in the buttock or upper arm once every 3 months (I3 weeks). To
continue your contraceptive protection, you must retum for your next injection promptly at the
end of 3 months (13 weeks). DEPO-PROVERA contains medroxyprogesterone acetate, a
chemical similar to (but not the same as) the natural hormone progesterone, which is produced
by your ovaries during the second haIf of your menstrual cycle. DEPO-PROVERA acts by
preventin your egg cells from ripening If an egg is not released from the ovaries during your
menstrua cyde, it cannot become fertiized by sperm and result in pregnancy DEPO-PROVERA
also a anges in the lining of your uterus that make it less likely or pregnancy to occur.
How effective is DEPO-PROVERA Contraceptive Injection?
The efficacy of DEPO-PROVERA Contraceptive Injection depends on following the
recommended dosage schedule exactly (see "How often do I get my shot of DEPO-PROVERA
Contraceptive Injection?"). To make sure you are not pregnant when you first get
DEPO-PROVERA Contraceptive Injection, your first injection mustabe given ONLY dunng
the first 5 days of a normal menstrual period; ONLY witin the first5 days after childbirth if not
breast-feeding and, if exclusively breast-feeding ONLY at the sixth week after childbirth. it is a
long-term in ectable contraceptive when administered at 3-month (13-week) intervals.
DEPO-PRO ERAContraceptive Injection is over 99% effective, making it one of the most reliable
methods of birth control available. This means that the average annual pregnancy rate is less than
one for every 100 women who use DEPO-PROVERA. The effectiveness of most contraceptive
methods depends in part on how reliably each woman uses the method. The effectiveness of
DEPO-PROVERA depends only on the patient returning every 3 months (13 weeks) for her next
injection. Your health-care provider will help you compare DEPO-PROVERA with other
contraceptive methods and give you the information you need in order to decide which
contraceptive method is the right choice for you.
The following table shows the percent of women who got pregnant while using different kinds of
contraceptive methods. t gives both the lowest expected rate of p regnancy (the rate expected
in women who use each method exactly as it should be used gan the typical rate of pregnancy
(which includes women who became pregnant because they forgot to use their birth control or
because they did not follow the directions exactly).
Percent of Women Experiencing an Accidental Pregnancy
in the First Year of Continuous Use

if you have had cancer of the breast
"if you have had a stroke
- if you have or have had blood clots (phlebitis) in your legs
- if you have problems with your liver or liver disease
. if you are allergic to DEPO-PROVERA (medroxyprogesterone acetate or any of its other
What other things should I consider before using DEPO-PROVERA
Contraceptive Injection?
You will have a physical examination before your doctor prescribes DEPO-PROVERA. It is
important to tell your health-care provider if you have any of the following:
" a family history of breast cancer
" an abnormal mammogram (breast x-ray), fibrocystic breast disease, breast nodules or lumps, or
bleeding from your nipples
- kidney disease
Sirregular or scanty menstrual periods
" high blood pressure
Smigraine headaches
"epilepsy (convulsions or seizures)
Sdiabetes or a family history of diabetes
"a history of depression
i if you are taking any prescription or over-the-counter medications
This product is intended to prevent pregnancy. It does not protect against
transmission of HIV (AIDS) and other sexually transmitted diseases such as
chiamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis.
What if I want to become pregnant after using DEPO-PROVERA Contraceptive
Because DEPO-PROVERA is a long-acting birth control method, it takes some time after your last
injection for its effect to wear offt Based on the results from a large study done in the United States,
for women who stop using DEPO-PROVERA in order to become pregnant, it is expected that
about half of those who become pregnant will do so in about 10 months2after their last injection;
about two thirds of those who become pregnant will do so in about 12 months; about 83% of
those who become pregnant will do so in about 15 months; and about 93% of those who become
re ant will do so in about 18 months after their last injection. The length of time you use
0 0-PRVERAhas no effect on how Io t takesyo to become penn after you stop usig it
What are the risks of using DEPO- ROV RA Contracept e injection?
I irregular Menstrual Bleeding
The side effect reported most frequently by women who use DEPO-PROVERA for
contrace ption is a change in their normal menstrual cycle. During the first year of using
DEPO-PROVERA, you might have one or more of the following changes: irregular or
unpredictable bleeding or spotting, an increase or decrease in menstrual bleeding, or no bleeding
at all. Unusually heavy or continuous bleeding, however; is not a usual effect of DEPO-PROVERA;
and if this hap pens, you should see your heaS-care provider right away. With continued use of
DEPO-PROVEPA, bleeding usually decreases, and many women stop having periods completely
In clinical studies of DEPO-PROVERA, 55% of the women studied eported no menstrual
bleeding (amenorrhea) after I year of use, and 68% of the women studied reported no menstrual
bleeding after 2 years of use. The reason that your periods stop is because DEPO-PROVERA
causes a resting state in your ovaries. When your ovaries do not release an egg monthly, the
regular monthly growth of the lining of your uterus does not occur and; therefore, the bleeding

6.Ocher Risks
Women who use hormone-based contraceptives may have an increased risk of blood clots or
stroke. Also, if a contraceptive method fails, there is a possibility that the fertilized egg will begin
to develop outside of the uterus (ectopic pregnancy). While these events are rare, you should
tell your health-care provider if you have any of the problems listed in the next section.
What symptoms may signal problems while using DEPO-PROVERA
Contraceptive Injection?
Call your health-care provider immediately if any of these problems occur following an injection
- sharp chest pain, coughing up of blood, or sudden shortness of breath (indicating a possible clot
in the lung)
" sudden severe headache or vomiting, dizziness or fainting, problems with your eyesight or
speech, weakness, or numbness in an arm or leg (indicating a possible stroke)
- severe pain or swelling in the calf (indicating a possible clot in the leg)
- unusualy heavy vaginal bleeding
" severe pain or tendemess in the lower abdominal area
persistent pain, pus, or bleeding at the injection site
Wh t aete possible side effects of DEPO-PROVERA Contraceptive Injection?
l.Weight Goin
You may experience a weight gain while you are using DEPO-PROVERA About two thirds of
the women who used DEPO-PROVERA in clinical trials reported a weight gain of about 5 pounds
during the first year of use. You may continue to gain weight after the first yeac Women in one
large study who used DEPO-PROVERA for 2 years gained an average total of 8.1 pounds over
those 2 years, or approximately 4 pounds per year Women who continued for 4 years gained an
average total of 13.8 pounds over those 4 years, or approximately 3.5 pounds per year Women
who continued for 6 years gained an average total of 16.5 pounds over those 6 years, or
approximate 2.75 pounds per year.
2.Drher Side Effects
In a clinical study of over 3,900 women who used DEPO-PROVERA for up to 7 years, some
women reported the following effects that may or may not have been related to their use of
DEPO-PROVERA: Irregular menstrual bleeding, amenorrhea, headache, nervousness, abdominal
cramps, dizz iness, weakness or fatigue, decreased sexual desire , leg cramps, nausea, vaginal
discharge or irritation, breast swelling and tendemess, bloating. swelling of the hands or feet,
backache, depression, insomnia, acne, pelvic pain, no hair growth or excessive hair loss, rash, hot
flashes, and joint pain. Other problems were reported by very few of the women in the clinical
trials, but some of these could be serious. These include convulsions, jaundice, urinary tract
infectons, allergic reactions, fainting, paralysis, osteoporosis, lack of retum to fertility deep vein
thrombosis, pulmonary embolus, breast cancer; or cervical cancer If these or any other problems
occur during your use of DEPO-PROVERA, discuss them with your health-care providec
Should any precautions be followed during use of DEPO-PROVERA
contraceptive Injection?
I.Missed Periods
During the time you are using DEPO-PROVERA for contraception, you may skip a period, or your
periods may stop completely If you have been receiving your DEPO-PROVERA injections
re gularly every 3 months (13 weeks), then you are probably not pregnant. However, if you think
that you may be pre gnan t, see your health-care provie
2.Loborocory Test Interoctions
If you are scheduled for any laboratory tests, tell your health-care provider that you are using
DPO-PROVERA for contraception. Certan bloodtests are affected by hormones such as

Method Expected Typical
Implants (Norplant) 0.2* 0.*
Female sterilization 0.2 0.4
Male sterilization 0.1 0.15
Oral contraceptive (pill) 3


Back to Top

© 2020 Regents of the University of Michigan